PT2336125E - Tiazolopiridina-2-iloxi-fenil e tiazolopirazin-2-iloxifenil aminas como moduladores de leucotrieno a4 hidrolase - Google Patents

Tiazolopiridina-2-iloxi-fenil e tiazolopirazin-2-iloxifenil aminas como moduladores de leucotrieno a4 hidrolase

Info

Publication number: PT2336125E
Authority: PT; Portugal
Prior art keywords: yloxy; phenyl; thiazolopyrazin; thiazolopyridin; leukotriene
Prior art date: 2008-04-11

Application number

PT111592366T

Other languages

English (en)

Inventor

Cheryl A Grice

Xiaohu Deng

Jimmy T Liang

Neelakandha S Mani

Genesis M Bacani

Diego Broggini

Eugene Y Cheung

Christa C Chrovian

Anne M Fourine

Laurent Gomez

Aaron M Kearney

Adrienne M Landry-Bayle

Alice Lee-Dutra

Susanne Lochner

Alejandro Santillan

Kathleen C Sappy

Kia Sepassi

Virginia M Tanis

Alvah T Wickboldt

John J M Wiener

Hartmut Zinser

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-11

Filing date

2009-04-09

Publication date

2013-03-18

2009-04-09 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2013-03-18 Publication of PT2336125E publication Critical patent/PT2336125E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Oncology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

PT111592366T 2008-04-11 2009-04-09 Tiazolopiridina-2-iloxi-fenil e tiazolopirazin-2-iloxifenil aminas como moduladores de leucotrieno a4 hidrolase PT2336125E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4434908P	2008-04-11	2008-04-11
US14912909P	2009-02-02	2009-02-02

Publications (1)

Publication Number	Publication Date
PT2336125E true PT2336125E (pt)	2013-03-18

Family

ID=41130551

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT97295968T PT2268646E (pt)	2008-04-11	2009-04-09	Aminas de tiazolopiridina-2-iloxi-fenil e de tiazolopirazina-2-iloxi-fenilo como moduladores da hidrolase de leucotrieno a4
PT111592366T PT2336125E (pt)	2008-04-11	2009-04-09	Tiazolopiridina-2-iloxi-fenil e tiazolopirazin-2-iloxifenil aminas como moduladores de leucotrieno a4 hidrolase

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT97295968T PT2268646E (pt)	2008-04-11	2009-04-09	Aminas de tiazolopiridina-2-iloxi-fenil e de tiazolopirazina-2-iloxi-fenilo como moduladores da hidrolase de leucotrieno a4

Country Status (36)

Country	Link
US (3)	US7939527B2 (pt)
EP (2)	EP2268646B9 (pt)
JP (2)	JP5530423B2 (pt)
KR (1)	KR101228378B1 (pt)
CN (1)	CN102056933B (pt)
AR (1)	AR072353A1 (pt)
AU (1)	AU2009234140B2 (pt)
BR (1)	BRPI0911336A2 (pt)
CA (1)	CA2721099C (pt)
CL (1)	CL2009000877A1 (pt)
CO (1)	CO6260069A2 (pt)
CY (1)	CY1114628T1 (pt)
DK (2)	DK2268646T3 (pt)
EA (1)	EA018802B1 (pt)
EC (1)	ECSP10010558A (pt)
ES (2)	ES2400875T3 (pt)
HK (2)	HK1152041A1 (pt)
HN (1)	HN2010002074A (pt)
HR (2)	HRP20130278T1 (pt)
IL (2)	IL208480A (pt)
JO (1)	JO2911B1 (pt)
MX (1)	MX2010011154A (pt)
MY (1)	MY157597A (pt)
NI (1)	NI201000168A (pt)
NZ (2)	NZ599853A (pt)
PE (1)	PE20091779A1 (pt)
PH (1)	PH12013500094A1 (pt)
PL (2)	PL2336125T3 (pt)
PT (2)	PT2268646E (pt)
RS (2)	RS52712B (pt)
SI (2)	SI2268646T1 (pt)
SV (1)	SV2010003694A (pt)
TW (2)	TWI461196B (pt)
UY (1)	UY31760A (pt)
WO (1)	WO2009126806A2 (pt)
ZA (1)	ZA201008054B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3205644A1 (en)	2005-12-29	2017-08-16	Celtaxsys Inc.	Diamine derivatives as inhibitors of leukotriene a4 hydrolase
RS52712B (en) *	2008-04-11	2013-08-30	Janssen Pharmaceutica N.V.	THIAZOLOPYRIDIN-2-ILOXY-PHENYL I THIAZOLOPYRZIN-2-ILOXY-PHENYL KAO MODULATOR FOR LEUKOTRIEN A4 HYDROLAZE
AR091315A1 (es) *	2012-03-06	2015-01-28	Boehringer Ingelheim Int	Inhibidores de benzodioxano de la produccion de leucotrieno
KR20140138851A (ko)	2012-03-06	2014-12-04	베링거 인겔하임 인터내셔날 게엠베하	류코트리엔 생성 억제를 위해 기타 활성제와 병용된 벤조디옥산
TW201416354A (zh)	2012-07-17	2014-05-01	Boehringer Ingelheim Int	白三烯生成抑制劑
EP2746260A1 (en)	2012-12-21	2014-06-25	Basf Se	Substituted [1,2,4]triazole and imidazole compounds
EP2746259A1 (en)	2012-12-21	2014-06-25	Basf Se	Substituted [1,2,4]triazole and imidazole compounds
AU2014249168B2 (en)	2013-03-12	2018-07-12	Celltaxis, Llc	Methods of inhibiting leukotriene A4 hydrolase
EP2968264A4 (en)	2013-03-14	2016-11-02	Celtaxsys Inc	INHIBITORS OF LEUCOTRIENE A4 HYDROLASE
CA2906086A1 (en) *	2013-03-14	2014-09-25	Celtaxsys, Inc.	Inhibitors of leukotriene a4 hydrolase
CA3102077A1 (en)	2018-05-31	2019-12-05	Sanjeev AHUJA	Method of reducing pulmonary exacerbations in respiratory disease patients
BR112021013637A2 (pt)	2019-01-11	2021-09-14	Naegis Pharmaceuticals Inc.	Inibidores da síntese de leucotrieno

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5008A (en) *		1847-03-13		Machinery for cleaning
IL59004A0 (en)	1978-12-30	1980-03-31	Beecham Group Ltd	Substituted benzamides their preparation and pharmaceutical compositions containing them
US4321378A (en)	1979-01-16	1982-03-23	Delalande S.A.	8-(5-Pyrimidinecarboxamide)nor-tropane derivatives
FR2446823A1 (fr)	1979-01-16	1980-08-14	Delalande Sa	Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique
FR2476088A2 (fr)	1979-01-16	1981-08-21	Delalande Sa	Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique
US4329466A (en)	1979-01-16	1982-05-11	Delalande S.A.	Certain nor-tropan-8-amine-3-aryl or heteroaryl derivatives
US4424358A (en)	1979-01-16	1984-01-03	Delalande S.A.	β-3-Amino nor-tropane compounds
US4352802A (en)	1980-06-10	1982-10-05	Beecham Group Limited	Bicyclo[3.3.1]nonyl-benzamide
NZ199080A (en)	1980-12-12	1984-07-31	Beecham Group Ltd	2-alkoxy-4-amino-5-alkylsulphonyl-n-(3beta-(8-hydrocarbyl-8-azabicyclo (3,2,1)octyl))benzamides
US4432983A (en)	1981-04-30	1984-02-21	Research Corporation	Conformationally restricted histamine H2 -receptor antagonists containing a tropane ring
DE3137996A1 (de) *	1981-09-24	1983-04-28	Hoechst Ag, 6230 Frankfurt	Heterocyclische phenylaether, verfahren zu deren herstellung und diese enthaltende herbizide mittel
US4571396A (en) *	1984-04-16	1986-02-18	Warner-Lambert Company	Antibacterial agents
US4873346A (en) *	1985-09-20	1989-10-10	The Upjohn Company	Substituted benzothiazoles, benzimidazoles, and benzoxazoles
NZ222047A (en)	1986-10-08	1991-01-29	Bristol Myers Co	Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
DK171349B1 (da) *	1986-11-14	1996-09-16	Hoffmann La Roche	Tetrahydronaphthalenderivater, fremgangsmåde til fremstilling deraf, lægemidler indeholdende forbindelserne samt anvendelse af forbindelserne til fremstilling af lægemidler
JPS63170356A (ja)	1986-12-30	1988-07-14	Yamanouchi Pharmaceut Co Ltd	アニリン誘導体及びその製造法
FI91859C (fi) *	1987-06-17	1994-08-25	Eisai Co Ltd	Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
US5070094A (en)	1989-09-05	1991-12-03	G. D. Searle & Co.	N-benzyltropaneamides
US5220063A (en) *	1991-05-10	1993-06-15	Hoechst Celanese Corporation	Method for the preparation of arylalkanolacylamides
US5296486A (en) *	1991-09-24	1994-03-22	Boehringer Ingelheim Pharmaceuticals, Inc.	Leukotriene biosynthesis inhibitors
US5472964A (en) *	1992-12-22	1995-12-05	Merck Frosst Canada, Inc.	Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
TW251287B (pt)	1993-04-30	1995-07-11	Nissei Co Ltd
US5585492A (en)	1994-10-11	1996-12-17	G. D. Searle & Co.	LTA4 Hydrolase inhibitors
US6506876B1 (en) *	1994-10-11	2003-01-14	G.D. Searle & Co.	LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5700816A (en) *	1995-06-12	1997-12-23	Isakson; Peter C.	Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
US6632976B1 (en) *	1995-08-29	2003-10-14	Kirin Beer Kabushiki Kaisha	Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
US5794887A (en)	1995-11-17	1998-08-18	Komerath; Narayanan M.	Stagnation point vortex controller
WO1997029774A1 (en)	1996-02-13	1997-08-21	G.D. Searle & Co.	Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
US6110994A (en) *	1996-06-14	2000-08-29	Cabot Corporation	Polymeric products containing modified carbon products and methods of making and using the same
US6110944A (en)	1997-03-12	2000-08-29	G. D. Searle & Co.	LTA4, hydrolase inhibitors
US6632823B1 (en)	1997-12-22	2003-10-14	Merck & Co., Inc.	Substituted pyridine compounds useful as modulators of acetylcholine receptors
US6432976B1 (en)	1999-10-29	2002-08-13	Merck & Co., Inc.	8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6559140B2 (en) *	2000-03-09	2003-05-06	Abbott Laboratories	Cyclic and bicyclic diamino histamine-3 receptor antagonists
MY145722A (en)	2000-04-27	2012-03-30	Abbott Lab	Diazabicyclic central nervous system active agents
FR2831884B1 (fr)	2001-11-02	2003-12-26	Pf Medicament	Nouveaux derives amides heteroaromatiques de 3 beta-amino azabicyclooctane, leur procede de preparation et leurs applications en therapeutique
EP1367481A3 (en) *	2002-05-29	2008-04-09	Hitachi, Ltd.	Centralized storage management method
US7329682B2 (en) *	2003-04-03	2008-02-12	Ewha University-Industry Collaboration Foundation	Method for inhibiting 5-lipoxygenase using a benzoxazole derivative
SE0301373D0 (sv) *	2003-05-09	2003-05-09	Astrazeneca Ab	Novel compounds
AU2004247627A1 (en)	2003-05-16	2004-12-23	Ambit Biosciences Corporation	Pyrrole compounds and uses thereof
CA2534212A1 (en) *	2003-07-28	2005-02-10	Janssen Pharmaceutica, N.V.	Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
US7825109B2 (en) *	2003-08-29	2010-11-02	Ono Pharmaceutical Co., Ltd.	Compound capable of binding S1P receptor and pharmaceutical use thereof
US7435831B2 (en) *	2004-03-03	2008-10-14	Chemocentryx, Inc.	Bicyclic and bridged nitrogen heterocycles
TW200610761A (en)	2004-04-23	2006-04-01	Astrazeneca Ab	Chemical compounds
CN101005838A (zh)	2004-06-22	2007-07-25	先灵公司	大麻素受体配体
GB2415818B (en)	2004-06-30	2008-12-31	Autoliv Dev	Arrangement for triggering a vehicle safety device
AU2005283326B2 (en)	2004-09-13	2011-07-21	Ono Pharmaceutical Co., Ltd.	Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
AU2006230379A1 (en) *	2005-03-31	2006-10-05	Janssen Pharmaceutica N.V.	Phenyl and pyridyl LTA4H modulators
ES2277745B1 (es)	2005-06-14	2008-06-01	Laboratorios Almirall S.A.	Derivados n-amida de 8-azabiciclo /3.2.1/oct-3-ilo como antagonistas de ccr1.
GB0514018D0 (en)	2005-07-07	2005-08-17	Ionix Pharmaceuticals Ltd	Chemical compounds
EP3205644A1 (en)	2005-12-29	2017-08-16	Celtaxsys Inc.	Diamine derivatives as inhibitors of leukotriene a4 hydrolase
US20090156465A1 (en)	2005-12-30	2009-06-18	Sattigeri Jitendra A	Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
JP5363315B2 (ja)	2006-06-06	2013-12-11	コーナーストーンセラピューティクスインコーポレイテッド	新規ピペラジン、医薬組成物、およびその使用方法
WO2008016811A2 (en)	2006-07-31	2008-02-07	Neurogen Corporation	Aminopiperidines and realted compounds
AU2007333667A1 (en) *	2006-12-19	2008-06-26	Auspex Pharmaceuticals, Inc.	Preperation and utility of CCR5 inhibitors
TW200906396A (en) *	2007-02-14	2009-02-16	Janssen Pharmaceutica Nv	LTA4H modulators and uses thereof
PA8802501A1 (es) *	2007-10-31	2009-06-23	Janssen Pharmaceutica Nv	Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno, hidrolasa
RS52712B (en) *	2008-04-11	2013-08-30	Janssen Pharmaceutica N.V.	THIAZOLOPYRIDIN-2-ILOXY-PHENYL I THIAZOLOPYRZIN-2-ILOXY-PHENYL KAO MODULATOR FOR LEUKOTRIEN A4 HYDROLAZE

2009
- 2009-04-09 RS RS20130120A patent/RS52712B/en unknown
- 2009-04-09 WO PCT/US2009/040070 patent/WO2009126806A2/en active Application Filing
- 2009-04-09 KR KR1020107025118A patent/KR101228378B1/ko active IP Right Grant
- 2009-04-09 PL PL11159236T patent/PL2336125T3/pl unknown
- 2009-04-09 US US12/421,406 patent/US7939527B2/en active Active
- 2009-04-09 PL PL09729596T patent/PL2268646T3/pl unknown
- 2009-04-09 ES ES11159236T patent/ES2400875T3/es active Active
- 2009-04-09 DK DK09729596.8T patent/DK2268646T3/da active
- 2009-04-09 NZ NZ599853A patent/NZ599853A/xx not_active IP Right Cessation
- 2009-04-09 MY MYPI2010004692A patent/MY157597A/en unknown
- 2009-04-09 CA CA2721099A patent/CA2721099C/en not_active Expired - Fee Related
- 2009-04-09 RS RS20130527A patent/RS53081B/en unknown
- 2009-04-09 ES ES09729596.8T patent/ES2440746T3/es active Active
- 2009-04-09 EP EP09729596.8A patent/EP2268646B9/en active Active
- 2009-04-09 SI SI200930743T patent/SI2268646T1/sl unknown
- 2009-04-09 EP EP11159236A patent/EP2336125B1/en active Active
- 2009-04-09 AU AU2009234140A patent/AU2009234140B2/en not_active Ceased
- 2009-04-09 JP JP2011504176A patent/JP5530423B2/ja not_active Expired - Fee Related
- 2009-04-09 EA EA201071186A patent/EA018802B1/ru unknown
- 2009-04-09 NZ NZ588341A patent/NZ588341A/en not_active IP Right Cessation
- 2009-04-09 SI SI200930535T patent/SI2336125T1/sl unknown
- 2009-04-09 CL CL2009000877A patent/CL2009000877A1/es unknown
- 2009-04-09 BR BRPI0911336-3A patent/BRPI0911336A2/pt not_active Application Discontinuation
- 2009-04-09 PT PT97295968T patent/PT2268646E/pt unknown
- 2009-04-09 CN CN200980122416.8A patent/CN102056933B/zh not_active Expired - Fee Related
- 2009-04-09 JO JO2009128A patent/JO2911B1/en active
- 2009-04-09 MX MX2010011154A patent/MX2010011154A/es active IP Right Grant
- 2009-04-09 PT PT111592366T patent/PT2336125E/pt unknown
- 2009-04-09 DK DK11159236.6T patent/DK2336125T3/da active
- 2009-04-10 TW TW098111909A patent/TWI461196B/zh not_active IP Right Cessation
- 2009-04-10 TW TW103104197A patent/TW201420100A/zh unknown
- 2009-04-13 AR ARP090101295A patent/AR072353A1/es unknown
- 2009-04-13 UY UY0001031760A patent/UY31760A/es unknown
- 2009-04-13 PE PE2009000508A patent/PE20091779A1/es active IP Right Grant
2010
- 2010-10-05 IL IL208480A patent/IL208480A/en active IP Right Grant
- 2010-10-11 HN HN2010002074A patent/HN2010002074A/es unknown
- 2010-10-11 SV SV2010003694A patent/SV2010003694A/es unknown
- 2010-10-11 NI NI201000168A patent/NI201000168A/es unknown
- 2010-10-20 EC EC2010010558A patent/ECSP10010558A/es unknown
- 2010-10-22 CO CO10131314A patent/CO6260069A2/es active IP Right Grant
- 2010-11-10 ZA ZA2010/08054A patent/ZA201008054B/en unknown
2011
- 2011-03-02 US US13/039,105 patent/US20110190503A1/en not_active Abandoned
- 2011-03-02 US US13/039,017 patent/US8357684B2/en not_active Expired - Fee Related
- 2011-06-16 HK HK11106213.5A patent/HK1152041A1/xx not_active IP Right Cessation
- 2011-11-24 HK HK11112776.2A patent/HK1158208A1/xx not_active IP Right Cessation
2013
- 2013-01-14 PH PH12013500094A patent/PH12013500094A1/en unknown
- 2013-03-27 HR HRP20130278AT patent/HRP20130278T1/hr unknown
- 2013-05-09 IL IL226244A patent/IL226244A/en active IP Right Grant
- 2013-11-20 CY CY20131101029T patent/CY1114628T1/el unknown
- 2013-12-16 HR HRP20131192AT patent/HRP20131192T1/hr unknown
- 2013-12-25 JP JP2013266767A patent/JP5675943B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AR072353A1 (es)	2010-08-25
JP5530423B2 (ja)	2014-06-25
EP2268646A2 (en)	2011-01-05
CY1114628T1 (el)	2016-10-05
SI2268646T1 (sl)	2013-12-31
ES2440746T3 (es)	2014-01-30
CL2009000877A1 (es)	2009-11-27
CN102056933B (zh)	2014-09-17
US20110159563A1 (en)	2011-06-30
DK2336125T3 (da)	2013-04-08
WO2009126806A2 (en)	2009-10-15
JP2011516571A (ja)	2011-05-26
EP2336125B1 (en)	2013-01-09
US7939527B2 (en)	2011-05-10
JP5675943B2 (ja)	2015-02-25
IL208480A (en)	2014-11-30
SV2010003694A (es)	2011-03-17
EP2336125A1 (en)	2011-06-22
AU2009234140A1 (en)	2009-10-15
KR20110013386A (ko)	2011-02-09
AU2009234140B2 (en)	2013-04-11
UY31760A (es)	2009-11-10
DK2268646T3 (da)	2013-11-18
MY157597A (en)	2016-06-30
EP2268646B1 (en)	2013-10-02
CA2721099A1 (en)	2009-10-15
HK1158208A1 (en)	2012-07-13
NI201000168A (es)	2015-05-27
JO2911B1 (en)	2015-09-15
EA201071186A1 (ru)	2011-06-30
TW201002320A (en)	2010-01-16
HRP20131192T1 (hr)	2014-01-17
US8357684B2 (en)	2013-01-22
NZ599853A (en)	2012-08-31
HN2010002074A (es)	2012-12-03
CO6260069A2 (es)	2011-03-22
HK1152041A1 (en)	2012-02-17
PT2268646E (pt)	2013-12-10
CN102056933A (zh)	2011-05-11
WO2009126806A8 (en)	2010-11-18
BRPI0911336A2 (pt)	2021-06-29
EP2268646B9 (en)	2014-11-19
HRP20130278T1 (en)	2013-06-30
PH12013500094B1 (en)	2015-02-23
NZ588341A (en)	2012-06-29
RS52712B (en)	2013-08-30
TWI461196B (zh)	2014-11-21
JP2014144949A (ja)	2014-08-14
RS53081B (en)	2014-06-30
IL226244A0 (en)	2013-06-27
US20090258854A1 (en)	2009-10-15
PL2268646T3 (pl)	2014-02-28
ES2400875T3 (es)	2013-04-15
IL208480A0 (en)	2010-12-30
EA018802B1 (ru)	2013-10-30
ZA201008054B (en)	2012-04-25
SI2336125T1 (sl)	2013-04-30
PL2336125T3 (pl)	2013-06-28
PE20091779A1 (es)	2009-11-14
IL226244A (en)	2014-12-31
KR101228378B1 (ko)	2013-01-31
US20110190503A1 (en)	2011-08-04
TW201420100A (zh)	2014-06-01
PH12013500094A1 (en)	2015-02-23
ECSP10010558A (es)	2010-11-30
CA2721099C (en)	2017-04-25
MX2010011154A (es)	2010-12-21
WO2009126806A3 (en)	2010-03-18

Publication	Publication Date	Title
IL226244A0 (en)	2013-06-27	Thiazolopyridine-2-yloxy-phenyl and thiazolopyrazine-2-yloxy-phenyl amines as leukotriene a4 hydrolase modulators
EP2217237A4 (en)	2011-08-17	ARYL-SUBSTITUTED, FUSED OR FUSED DIAMINES AS MODULATORS OF LEUKOTRIENE A <SB> 4 </ SB> HYDROLASE
GB2472856B (en)	2012-07-11	IL1-RAP modulators and uses thereof
IL247595A0 (en)	2016-11-30	New modulators and methods of use
HK1222799A1 (zh)	2017-07-14	作為血管生成和血管發生調節劑的
EP2441257A4 (en)	2012-05-02	MEDIA BRIDGE DEVICE AND METHOD
IL213072A0 (en)	2011-07-31	Microorganism comprising particles and uses of same
ZA201102674B (en)	2011-12-28	Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
EP2299931A4 (en)	2015-07-01	CLOSURE DEVICE AND METHODS OF USE THEREOF
SG10201601792UA (en)	2016-04-28	Novel modulators and methods of use
HK1149933A1 (en)	2011-10-21	Diazacarbazoles and methods of use
EP2318985A4 (en)	2011-08-24	ECONOMIC MEDIA AND MARKETING SYSTEM
IL209548A0 (en)	2011-01-31	Diazacarbazoles and methods of use
ZA201601457B (en)	2019-04-24	Modulators of 5-ht receptors and methods of use thereof
HK1164958A1 (en)	2012-09-28	Surface composition and method of application
EP2346425A4 (en)	2012-04-18	MODULATED STRAIN APPARATUS AND METHODS OF USE
EP2399749A4 (en)	2016-12-28	PRINTER DEVICE AND MAINTENANCE METHOD THEREFOR
PL2519939T3 (pl)	2017-04-28	Sposób, obiekt i ich zastosowanie do mocowania plakatów
EP2346894A4 (en)	2012-04-18	TERMOSTABLE CELLULASE AND USE METHOD
TH0901001693A (th)	2016-05-19	ไธแอโซโลพิริดิน-2-อิลออกซิ-เฟนิล และไธแอโซโลพิแรซิน-2-อิลออกซิ-เฟนิล แอมีนเป็นมอดูเลเตอร์ของลิวโคไทรอีน a4 ไฮโดรเลส
AU2009903644A0 (en)	2009-08-20	S1P Receptors Modulators and their use Thereof
IL183025A0 (en)	2007-09-20	Center of marketing and advertising